Inflammatory Bowel Disease Treatment Market
According to Intent Market Research, the Inflammatory Bowel Disease Treatment Market is expected to grow from USD 15.0 Billion in 2024-e at a CAGR of 8.5% to touch USD 24.5 Billion by 2030. The Inflammatory Bowel Disease Treatment Market is dominated by key players such as Johnson & Johnson, AbbVie Inc., Pfizer Inc., Merck & Co., Inc., Bristol Myers Squibb, and Takeda Pharmaceutical Company.